Cost Variability of Suggested Generic Treatment Alternatives Under the Medicare Part D Benefit

BACKGROUND: The substitution of generic treatment alternatives for brand-name drugs is a strategy that can help lower Medicare beneficiary out-of-pocket costs. Beginning in 2011, Medicare beneficiaries reaching the coverage gap received a 50% discount on the full drug cost of brand-name medications...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Rajul A., Walberg, Mark P., Tong, Emily, Tan, Florence, Rummel, Ashley E., Woelfel, Joseph A., Carr-Lopez, Sian M., Galal, Suzanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437590/
https://www.ncbi.nlm.nih.gov/pubmed/24564812
http://dx.doi.org/10.18553/jmcp.2014.20.3.283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437590/
https://www.ncbi.nlm.nih.gov/pubmed/24564812
http://dx.doi.org/10.18553/jmcp.2014.20.3.283

Ejemplares similares